• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BMP Medical Expands Sterling, Massachusetts Facility

    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

    Environmental Sustainability Becoming Increasingly Important to Medtech Industry

    Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board

    Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Medbio LLC

    Forefront Medical Technology

    Paragon Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Paragon Medical

    LEMO USA Inc.

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Humacyte Appoints President and CEO

    Long-time chairman and CEO is named executive chairman.

    Humacyte Appoints President and CEO
    Jeffrey Lawson, M.D., Ph.D., is Humacyte’s new president and CEO. Image courtesy of Humacyte.
    Related CONTENT
    • Pandemic has Accelerated Nearshoring Medtech Materials
    • Smaller Devices Require More Efficient Material Integration
    • Pandemic Underscores Importance of Medtech Material Innovation
    • 3D Systems Sells Simbionix to Surgical Sciences for $305M
    • Disinfectant Resistance is Crucial in Medtech Material Selection
    Business Wire07.31.18
    Humacyte, an innovator in biotechnology and regenerative medicine, has appointed Jeffrey Lawson M.D., Ph.D., as president and CEO. Carrie S. Cox has assumed the role of executive chairman.
     
    Lawson, an innovator, scientist and vascular surgeon, has been involved in the development of Humacyte’s vascular technologies, in collaboration with his career-long research partner and Humacyte founder Dr. Laura Niklason, over the past 20 years. Lawson has worked with Humacyte since its founding in 2004 to support the science, preclinical and clinical testing of Humacyte’s novel tissue engineered blood vessels, which are being developed for dialysis access and cardiovascular surgery. He was appointed chief medical officer of Humacyte in 2015 to oversee the clinical development of these vascular technologies as the company initiated Phase III clinical trials for dialysis access and expanded clinical programs in vascular repair and trauma.
     
    Prior to joining Humacyte, Lawson served in leadership roles at Duke University Medical Center, including professor of Surgery and Pathology, vice chair for Research in Surgery, and director of Clinical Trials for the Department of Surgery. Lawson earned his medical degree and his Ph.D. in cell and molecular biology from the University of Vermont and completed his residency in general and thoracic surgery and his fellowship in vascular surgery at Duke University Medical Center. Lawson is also an American Board of Surgery-certified vascular surgeon, a Fellow of the American Surgical Association and the current president of the Vascular Access Society of the Americas.
     
    “Under Carrie’s leadership, the organization has delivered remarkable progress in its first product candidate, catching the attention of research institutions, key opinion leaders, clinical sites, and investors all over the world,” said Lawson. “I look forward to continuing that work, along with the team at Humacyte. It will be my honor and privilege to lead the Humacyte team into the future as we continue to develop tissues to improve the lives of dialysis patients and expand our pipeline of product candidates, with the objective of helping patients in need of vascular repair and reconstruction.”
     
    As executive chairman, Cox will serve as a senior, strategic advisor to Lawson and the executive team, helping to develop ongoing strategy for Humacyte as the company works toward regulatory approval and commercialization for the investigational Human Acellular Vessel (HAV), HUMACYL.
     
    Since joining Humacyte as chairman and CEO in 2010, Cox has led the company through significant business, clinical, regulatory and operational milestones. She has guided the company’s clinical review process, including its ongoing pivotal Phase III clinical trials to evaluate the efficacy and safety of the bioengineered blood vessel as a conduit for hemodialysis in patients with end-stage renal disease (ESRD). Most recently, she led the negotiation of a strategic global commercialization partnership with Fresenius Medical Care to potentially make HUMACYL available to more patients worldwide following approval of the product.
     
    “Leading Humacyte has been one the most fulfilling and rewarding experiences of my career. I’m impressed by and proud of the incredible achievements of our team, as we strive to make science a reality for patients and physicians,” said Cox. “Our work to transform vascular medicine and tissue therapy has only just begun, and under the leadership of Dr. Lawson, I’m confident we are well positioned to further advance the boundaries of regenerative medicine and vascular therapeutics. With a track record of success in our own clinical development, Dr. Lawson is uniquely positioned to lead Humacyte through our next stage of growth and pipeline development.”
     
    Prior to serving as Humacyte’s chief medical officer, Lawson served as a consultant and advisor in the development of the investigational HAV. As an investigator in Humacyte’s Phase II clinical research program in hemodialysis, in 2013 he and Niklason, were the first to implant Humacyte’s investigational HAV for vascular access into a patient diagnosed with ESRD. “The development of Humacyte’s first-in-class therapeutics has always required a team that is committed, extremely talented, and visionary. With Jeff’s appointment to the CEO role, we are continuing our great tradition of outstanding leadership as we continue our work to develop transformative and meaningful tissues in the regenerative medicine space,” said Niklason.
     
    Humacyte Inc., a privately held company founded by Niklason, M.D., Ph.D., in 2004, is a medical research, discovery and development company with clinical and pre-clinical stage investigational products.
     
    Humacyte is primarily focused on developing and commercializing a proprietary novel technology based on human tissue-based products for key applications in regenerative medicine and vascular surgery. The company uses its proprietary platform technology to engineer human extracellular matrix-based tissues that can be shaped into tubes, sheets, or particulate conformations, with properties similar to native tissues. These are being developed for potential use in many specific applications, with the goal to significantly improve treatment outcomes for many patients, including those with vascular disease and those requiring hemodialysis. The company’s proprietary technologies are designed to create off-the-shelf products that, once approved, can be utilized in any patient.
     
    Related Searches
    • testing
    • human
    • 2015
    • extracellular matrix
    Suggested For You
    Pandemic has Accelerated Nearshoring Medtech Materials Pandemic has Accelerated Nearshoring Medtech Materials
    Smaller Devices Require More Efficient Material Integration Smaller Devices Require More Efficient Material Integration
    Pandemic Underscores Importance of Medtech Material Innovation Pandemic Underscores Importance of Medtech Material Innovation
    3D Systems Sells Simbionix to Surgical Sciences for $305M 3D Systems Sells Simbionix to Surgical Sciences for $305M
    Disinfectant Resistance is Crucial in Medtech Material Selection Disinfectant Resistance is Crucial in Medtech Material Selection
    Electronics Integration Impacting Medtech Materials Electronics Integration Impacting Medtech Materials
    Aziyo Biologics Begins De Novo CanGaroo Clinical Study Aziyo Biologics Begins De Novo CanGaroo Clinical Study
    Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    Home Is Where the Heart (Valve) Is Home Is Where the Heart (Valve) Is
    New Biomaterials Can be ‘Fine-Tuned’ for Medical Applications New Biomaterials Can be ‘Fine-Tuned’ for Medical Applications
    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    A Brain Injury Diagnosed with a Single Drop of Blood A Brain Injury Diagnosed with a Single Drop of Blood
    Medicen Paris Region Appoints CEO Medicen Paris Region Appoints CEO
    16. Fresenius Group 16. Fresenius Group
    Axolotl Biologix and Leonhardt Ventures to Study Combination Bioelectric and Biologic Therapies Axolotl Biologix and Leonhardt Ventures to Study Combination Bioelectric and Biologic Therapies

    Related Online Exclusives

    • Materials
      Pandemic has Accelerated Nearshoring Medtech Materials

      Pandemic has Accelerated Nearshoring Medtech Materials

      Buying materials from overseas may be cost-effective, but it can create an environment with less collaboration and less room for innovation.
      Michael Barbella, Managing Editor 08.06.21

    • Materials
      Smaller Devices Require More Efficient Material Integration

      Smaller Devices Require More Efficient Material Integration

      Silicones are becoming increasingly well-suited for implantable medical devices and combination products.
      Michael Barbella, Managing Editor 08.03.21

    • Materials
      Pandemic Underscores Importance of Medtech Material Innovation

      Pandemic Underscores Importance of Medtech Material Innovation

      Materials must meet the changing needs of medtech and society in general through preventative, diagnostic and therapeutic solutions.
      Michael Barbella, Managing Editor 07.30.21


    • 3D/Additive Manufacturing | Software & IT
      3D Systems Sells Simbionix to Surgical Sciences for $305M

      3D Systems Sells Simbionix to Surgical Sciences for $305M

      Divestiture results from company’s singular focus on additive manufacturing.
      3D Systems 07.29.21

    • Materials
      Disinfectant Resistance is Crucial in Medtech Material Selection

      Disinfectant Resistance is Crucial in Medtech Material Selection

      Understanding the kinds of materials that stand up to healthcare-grade disinfectants can help ensure device longevity.
      Michael Barbella, Managing Editor 07.27.21

    Loading, Please Wait..

    Trending
    • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
    • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Tandem Diabetes Completes Deal For AMF Medical
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    • Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    • Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board
    • Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login